Source link : https://www.newshealth.biz/health-news/new-leukemia-txs-fewer-blood-clots-with-glp-1-rxs/
SAN DIEGO — Groundbreaking studies into leukemia treatments and the effects of glucagon-like peptide 1 (GLP-1) inhibitors on venous thromboembolism (VTE) risk will be presented on December 9-12 at the American Society of Hematology (ASH) 2024 Annual Meeting, according to association leaders who spoke in a media preview session. Here’s a closer look at some […]
Author : News Health
Publish date : 2024-12-02 10:15:15
Copyright for syndicated content belongs to the linked Source.